A Phase Ii Study Of Lag525 In Combination With Spartalizumab (Pdr001), Pdr001 And Carboplatin (Carbo), Or Carbo, As First- Or Second-Line Therapy In Patients (Pts) With Advanced (Adv) Triple-Negative Breast Cancer (Tnbc)
ANNALS OF ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要